{
    "clinical_study": {
        "@rank": "6502", 
        "arm_group": [
            {
                "arm_group_label": "calcium ascorbate", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "ascorbic acid", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare levels of vitamin C in the blood over the 24 hour\n      period following a single 1000 mg dose of vitamin C from ascorbic acid, calcium ascorbate\n      and placebo."
        }, 
        "brief_title": "Comparative Bioavailability of Two Forms of Vitamin C", 
        "condition": "Bioavailability", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy as determined by laboratory results and medical history\n\n          -  Females not of child bearing potential\n\n          -  BMI 18-30 kg/m2\n\n          -  Agrees to consume a low vitamin C diet\n\n          -  Non-smoker or ex-smoker >1 year\n\n        Exclusion Criteria:\n\n          -  Pregnant, breastfeeding, or planning to become pregnant during the trial\n\n          -  Alcohol >2 drinks per day; alcohol or drug abuse within the past year\n\n          -  Cardiac conditions\n\n          -  Duodenal ulcer or gastric ulcer, gastritis, hiatus hernia, or gastroesophageal reflux\n             disease (GERD) within past 3 months\n\n          -  History irritable bowel syndrome, malabsorption or significant GI disease\n\n          -  History of kidney stones\n\n          -  Use of medications known to interact with vitamin C\n\n          -  Use of supplements containing vitamin C\n\n          -  Use of anticoagulants (warfarin), barbiturates, tetracycline antibiotics,\n             beta-blockers, cyclosporine, prednisone, tricyclic antidepressants, diuretics and\n             nitrate medications\n\n          -  History of or current diagnosis of cancer\n\n          -  Uncontrolled hypertension\n\n          -  History of diabetes, renal disease and/or liver disease\n\n          -  Unstable psychiatric disorder\n\n          -  History of or current immunocompromise\n\n          -  History of hemochromatosis or hemoglobinopathies\n\n          -  Participation in a clinical research trial <30 days\n\n          -  Use of acute medication w/in 72 hours of intervention\n\n          -  Unstable medications <90 days\n\n          -  Abnormal liver function\n\n          -  Serum creatinine > 1.5 x upper limit of normal (ULN)\n\n          -  Anemia of any etiology\n\n          -  Blood donation w/in the last 2 months\n\n          -  Allergy or sensitivity to test articles, foods or beverages provided during the study\n\n          -  Cognitive impairment and/or unable to give informed consent"
            }, 
            "gender": "Both", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01852903", 
            "org_study_id": "11CIHE"
        }, 
        "intervention": [
            {
                "arm_group_label": "calcium ascorbate", 
                "intervention_name": "calcium ascorbate", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "vitamin C"
            }, 
            {
                "arm_group_label": "ascorbic acid", 
                "intervention_name": "ascorbic acid", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "vitamin C"
            }, 
            {
                "arm_group_label": "placebo", 
                "intervention_name": "placebo", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Ascorbic Acid", 
                "Vitamins", 
                "Calcium, Dietary"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "vitamin C", 
            "calcium ascorbate", 
            "ascorbic acid", 
            "bioavailability"
        ], 
        "lastchanged_date": "May 9, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "London", 
                    "country": "Canada", 
                    "state": "Ontario", 
                    "zip": "N6A 5R8"
                }, 
                "name": "KGK Synergize Inc"
            }
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "3", 
        "official_title": "A Randomized, Double-blind, Placebo-controlled Crossover Study Comparing the Bioavailability of Two Forms of Vitamin C in Plasma and Leukocytes Over 24 Hours.", 
        "overall_official": {
            "affiliation": "KGK Synergize Inc.", 
            "last_name": "Dale R Wilson, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Canada: Health Canada"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Plasma and leukocyte vitamin C concentration", 
            "safety_issue": "No", 
            "time_frame": "0, 2, 4, 8 and 24 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01852903"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "NBTY, Inc.", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "KGK Synergize Inc.", 
                    "agency_class": "Industry"
                }, 
                {
                    "agency": "Moyad, Mark MD MPH", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "NBTY, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}